MINIMALLY INVASIVE GLAUCOMA SURGICAL TECHNIQUES FOR OPEN-ANGLE GLAUCOMA : A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/w7v03m86Keywords:
Minimally Invasive Glaucoma Surgery, Open-Angle GlaucomaAbstract
Background: Glaucoma affects more than 75 million people worldwide. Intraocular pressure (IOP) lowering surgery is an important treatment for this disease. Interest in reducing surgical morbidity has led to the introduction of minimally invasive glaucoma surgeries (MIGS). Understanding the comparative effectiveness and safety of MIGS is necessary for clinicians and patients.
Methods: By comparing itself to the standards set by the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 2020, this study was able to show that it met all of the requirements. So, the experts were able to make sure that the study was as up-to-date as it was possible to be. For this search approach, publications that came out between 2013 and 2023 were taken into account. Several different online reference sources, like Pubmed and SagePub, were used to do this. It was decided not to take into account review pieces, works that had already been published, or works that were only half done.
Result: In the PubMed database, the results of our search brought up 318 articles, whereas the results of our search on SagePub brought up 34 articles. The results of the search conducted for the last year of 2013 yielded a total 13 articles for PubMed and 12 articles for SagePub. In the end, we compiled a total of 5 papers, 4 of which came from PubMed and 1 of which came from SagePub. We included five research that met the criteria.
Conclusion: Although MIGS seem efficient in the reduction of the IOP and glaucoma medication and show good safety profile, this evidence is mainly derived from non-comparative studies and further, good quality RCTs are warranted.
References
Newman-Casey PA, Robin AL, Blachley T, Farris K, Heisler M, Resnicow K, et al. Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey. Ophthalmology
Bicket AK, Le JT, Azuara-Blanco A, Gazzard G, Wormald R, Bunce C, et al. Minimally Invasive Glaucoma Surgical Techniques for Open-Angle Glaucoma. JAMA Ophthalmol. 2021;139(9):1–7.
Li T, Lindsley K, Rouse B, Hong H, Shi Q, Friedman DS, et al. Comparative Effectiveness of First-line Medications for Primary Open Angle Glaucoma – A Systematic Review and Network Meta-analysis. Ophthalmology
Fellman RL, Mattox C, Singh K, Flower B, Francis BA, Robin AL, et al. American Glaucoma Society Position Paper: Microinvasive Glaucoma Surgery. Ophthalmol Glaucoma. 2020;3(1):1–6.
Spaeth GL, Cvintal V, Figueiredo A. Is There a Need for New Surgical Procedures for Glaucoma Yes Open Ophthalmol J
Richter GM, Coleman AL. Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol
Manassess DT, Au L. The New Era of Glaucoma Micro-stent Surgery. Ophthalmol Ther
Klamann MKJ, Gonnermann J, Maier AKB, Ruokonen PC, Torun N, Joussen AM, et al. Combined clear cornea phacoemulsification in the treatment of pseudoexfoliative glaucoma associated with cataract: significance of trabecular aspiration and ab interno trabeculectomy. Graefes Arch Clin Exp Ophthalmol. 2013;251(9):2195–9.
Fea AM, Belda JI, Rekas M, Junemann A, Chang L, Pablo L, et al. Prospective unmasked randomized evaluation of the iStent inject versus two ocular hypotensive agents in patients with primary open-angle glaucoma. Clin Ophthalmol. 2014;8:875–82.
Katz LJ, Erb C, Carceller GA, Fea AM, Voskanyan L, Wells JM, et al. Prospective, randomized study of one, two, or three trabecular bypass stents in open-angle glaucoma subjects on topical hypotensive medication. Clin Ophthalmol. 2015;9:2313–20.
Fea AM, Consolandi G, Zola M, Pignata G, Cannizzo P, Lavia C, et al. Micro-Bypass Implantation for Primary Open-Angle Glaucoma Combined with Phacoemulsification: 4-Year Follow-Up. J Ophthalmol . 2015;
Kurji K, Rudnisky CJ, Rayat JS, Arora S, Sandhu S, Damji KF, et al. Phaco-trabectome versus phaco-iStent in patients with open-angle glaucoma. Can J Ophthalmol. 2017;52(1):99–106.
Gumani B, Tripathy K. Minimally Invasive Glaucoma Surgery. StatPearls
Lavia C, Dallorto L, Maule M, Ceccarelli M, Fea AM. Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis. PLoS One. 2017;12(8).
SooHoo JR, Seibold LK, Radcliffe NM, Kahook MY. Minimally invasive glaucoma surgery: current implants and future innovations. Can J Ophthalmol. 2014;49(6):528–33.
Mathew DJ, Buys YM. Minimally Invasive Glaucoma Surgery: A Critical Appraisal of the Literature. Annu Rev Vis Sci. 2020;15(6):47–89.
Ahmed IIK. MIGS and the FDA: What’s in a Name Ophthalmology. 2015
Bloom P, Au L. Minimally Invasive Glaucoma Surgery (MIGS) Is a Poor Substitute for Trabeculectomy The Great Debate. Ophthalmol Ther
Gedde SJ, Chen PP, Heuer DK, Singh K, Wright MM, Feuer WJ, et al. The Primary Tube Versus Trabeculectomy Study: Methodology of a Multicenter Randomized Clinical Trial Comparing Tube Shunt Surgery and Trabeculectomy with Mitomycin C. Ophthalmology. 2018;125(5):774–81.
Agrawal P, Bradshaw SE. Systematic Literature Review of Clinical and Economic Outcomes of Micro-Invasive Glaucoma Surgery (MIGS) in Primary Open-Angle Glaucoma. Ophthalmol Ther. 2018;49–73.
Balas M, Mathew DJ. Minimally Invasive Glaucoma Surgery: A Review of the Literature. Vol. 7, Vision (Switzerland). Multidisciplinary Digital Publishing Institute (MDPI); 2023.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Journal of Advanced Research in Medical and Health Science (ISSN 2208-2425)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
